What Is the Role of Serologic Testing in Celiac Disease? A Prospective, Biopsy-Confirmed Study With Economic Analysis

Clinical Gastroenterology and Hepatology

Volumn 6, Issue 3, 2008, Pages 314-320

  Hopper, Andrew D ^a   Hadjivassiliou, Marios ^a   Hurlstone, David P ^a   Lobo, Alan J ^a   McAlindon, Mark E ^a   Egner, William ^b   Wild, Graeme ^b   Sanders, David S ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ENDOMYSIUM ANTIBODY; GLIADIN; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CELIAC DISEASE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DUODENUM BIOPSY; ECONOMIC EVALUATION; FEMALE; GASTROSCOPY; GLUTEN FREE DIET; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; INTESTINE VILLUS ATROPHY; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SERODIAGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTI-IDIOTYPIC; BIOPSY; CELIAC DISEASE; COSTS AND COST ANALYSIS; DIAGNOSIS, DIFFERENTIAL; DUODENUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEROLOGIC TESTS; SEVERITY OF ILLNESS INDEX;

EID: 39849087861     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.12.008     Document Type: Article

References (46)

1. Fasano A., Berti I., Gerarduzzi T., et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163 (2003) 286-292
2. Bingley P.J., Williams A.J., Norcross A.J., et al. Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. BMJ 328 (2004) 322-323
3. West J., Logan R.F., Hill P.G., et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 52 (2003) 960-965
4. Sanders D.S., Patel D., Stephenson T.J., et al. A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 15 (2003) 407-413
5. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Revised criteria for diagnosis of coeliac disease. Arch Dis Child 65 (1990) 909-911
6. United European Gastroenterology Working Group. When is a coeliac a coeliac?. Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol 13 (2001) 1123-1128
7. National Institutes of Health. Consensus Development Conference Statement on Celiac Disease, June 28-30, 2004. Gastroenterology 128 1 (2005) S1-S9
8. AGA Institute Medical Position Statement on. the Diagnosis and Management of Celiac Disease. Gastroenterology 131 (2006) 1977-1980
9. Lewis N.R., and Scott B.B. Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther 24 (2006) 47-54
10. Hill I.D. What are the sensitivity and specificity of serologic tests for celiac disease?. Do sensitivity and specificity vary in different populations?. Gastroenterology 128 Suppl 1 (2005) S25-S32
11. Rostom A., Dube C., Cranney A., et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 128 Suppl 1 (2005) S38-S46
12. Hill P.G., and McMillan S.A. Anti-tissue transglutaminase antibodies and their role in the investigation of coeliac disease. Ann Clin Biochem 43 (2006) 105-117
13. Hill P.G., Forsyth J.M., Semeraro D., et al. IgA antibodies to human tissue transglutaminase: audit of routine practice confirms high diagnostic accuracy. Scand J Gastroenterol 39 (2004) 1078-1082
14. Volta U., De Franceschi L., Molinaro N., et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci 43 (1998) 2190-2195
15. Clemente M.G., Musu M.P., Frau F., et al. Antitissue transglutaminase antibodies outside celiac disease. J Pediatr Gastroenterol Nutr 34 (2002) 31-34
16. Collin P., Kaukinen K., Vogelsang H., et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 17 (2005) 85-91
17. Abrams J.A., Diamond B., Rotterdam H., et al. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci 49 (2004) 546-550
18. Tursi A., Brandimarte G., and Giorgetti G.M. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol 36 (2003) 219-221
19. Hopper A.D., Cross S.S., Hurlstone D.P., et al. Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ 334 (2007) 729
20. Tonutti E., Visentini D., Bizzaro N., et al. The role of antitissue transglutaminase assay for the diagnosis and monitoring of coeliac disease: a French-Italian multicentre study. J Clin Pathol 56 (2003) 389-393
21. Reeves G.E., Squance M.L., Duggan A.E., et al. Diagnostic accuracy of coeliac serological tests: a prospective study. Eur J Gastroenterol Hepatol 18 (2006) 493-501
22. Ciacci C., Cirillo M., Cavallaro R., et al. Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion 66 (2002) 178-185
23. Tursi A., Brandimarte G., Giorgetti G.M., et al. Endoscopic and histological findings in the duodenum of adults with celiac disease before and after changing to a gluten-free diet: a 2-year prospective study. Endoscopy 38 (2006) 702-707
24. Grefte J.M., Bouman J.G., Grond J., et al. Slow and incomplete histological and functional recovery in adult gluten sensitive enteropathy. J Clin Pathol 41 (1988) 886-891
25. Dickey W., Hughes D.F., and McMillan S.A. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol 95 (2000) 712-714
26. Feighery C., Weir D.G., Whelan A., et al. Diagnosis of gluten-sensitive enteropathy: is exclusive reliance on histology appropriate?. Eur J Gastroenterol Hepatol 10 (1998) 919-925
27. Shidrawi R.G., Przemioslo R., Davies D.R., et al. Pitfalls in diagnosing coeliac disease. J Clin Pathol 47 (1994) 693-694
28. Dickson B.C., Streutker C.J., and Chetty R. Coeliac disease: an update for pathologists. J Clin Pathol 59 (2006) 1008-1016
29. Oberhuber G., Granditsch G., and Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 11 (1999) 1185-1194
30. Hadjivassiliou M., Grunewald R.A., and Davies-Jones G.A. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry 72 (2002) 560-563
31. Agardh D. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Clin Gastroenterol Hepatol 5 (2007) 1276-1281
32. Sugai E., Vazquez H., Nachman F., et al. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Clin Gastroenterol Hepatol 4 (2006) 1112-1117
33. Bardella M.T., Trovato C., Cesana B.M., et al. Serological markers for coeliac disease: is it time to change?. Dig Liver Dis 33 (2001) 426-431
34. Chan A.W., Butzner J.D., McKenna R., et al. Tissue transglutaminase enzyme-linked immunosorbent assay as a screening test for celiac disease in pediatric patients. Pediatrics 107 (2001) E8
35. Lock R.J., Stevens S., Pitcher M.C., et al. Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease?. Eur J Gastroenterol Hepatol 16 (2004) 467-470
36. Vecchi M., Folli C., Donato M.F., et al. High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source. Scand J Gastroenterol 38 (2003) 50-54
37. Peracchi M., Trovato C., Longhi M., et al. Tissue transglutaminase antibodies in patients with end-stage heart failure. Am J Gastroenterol 97 (2002) 2850-2854
38. Rostami K., Kerckhaert J.P., Tiemessen R., et al. The relationship between anti-endomysium antibodies and villous atrophy in coeliac disease using both monkey and human substrate. Eur J Gastroenterol Hepatol 11 (1999) 439-442
39. Freeman H.J. Strongly positive tissue transglutaminase antibody assays without celiac disease. Can J Gastroenterol 18 (2004) 25-28
40. Bazzigaluppi E., Roggero P., Parma B., et al. Antibodies to recombinant human tissue-transglutaminase in coeliac disease: diagnostic effectiveness and decline pattern after gluten-free diet. Dig Liver Dis 38 (2006) 98-102
41. Mahadeva S., Wyatt J.I., and Howdle P.D. Is a raised intraepithelial lymphocyte count with normal duodenal villous architecture clinically relevant?. J Clin Pathol 55 (2002) 424-428
42. Korponay-Szabo I.R., Dahlbom I., Laurila K., et al. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Gut 52 (2003) 1567-1571
43. Gillett H.R., and Freeman H.J. Comparison of IgA endomysium antibody and IgA tissue transglutaminase antibody in celiac disease. Can J Gastroenterol 14 (2000) 668-671
44. Vahedi K., Mascart F., Mary J.Y., et al. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 98 (2003) 1079-1087
45. Kaukinen K., Sulkanen S., Maki M., et al. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol 14 (2002) 311-315
46. Kaukinen K., Peraaho M., Lindfors K., et al. Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease. Aliment Pharmacol Ther 25 (2007) 1237-1245